Portfolio company
Bluefin Biomedicine
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops first-in-class antibody medicines for patients with serious inflammatory and oncologic diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Beeline Medicines
This clinical-stage biotechnology company develops precision therapies for patients living with autoimmune and inflammatory diseases.
Clim Bio
This biotechnology company develops antibody-based medicines for patients with immune-mediated diseases such as lupus and IgA nephropathy.
Evommune
This biotechnology company develops medicinal therapies to treat patients suffering from chronic inflammatory and immune-mediated diseases.
Hummingbird Bioscience
This company develops antibody-based therapeutics and drug conjugates for patients with hard-to-treat cancers and autoimmune diseases.
Infinimmune
This biotechnology company develops human-derived antibody therapeutics for pharmaceutical partners and patients with atopic dermatitis and other inflammatory diseases.
Attovia Therapeutics
The company develops biparatopic biologics to treat patients with immune-mediated diseases and cancer through a modular protein design platform.
Serif Biomedicines
This biotechnology firm develops modified DNA medicines for patients with genetically defined diseases and immune system conditions.
Ankyra Therapeutics
This biotechnology company develops anchored immunotherapy treatments for patients with cancer and other serious immune-mediated diseases.
